Thrombosis rates in patients with multiple myeloma: prospective phase 2 trials of thromboprophylaxis.
| Reference, disease status . | No. patients . | Therapy . | Thrombosis, n (%) . |
|---|---|---|---|
| Abbreviations: CT, chemotherapy; DX, dexamethasone; T, thalidomide; ASA, aspirin. | |||
| Modified from Falanga and Marchetti44 with permission from the publishers. | |||
| Zangari M et al, 200430 | 68 | CT + DX + T + Enoxaparin (40 mg/d) | 10 (14.7) |
| Newly diagnosed | 35 | CT + DX + T + Warfarin (1 mg/d) | 11 (31.4) |
| Minnema MC et al, 200331 | 209 | CT + DX + T + Nadroparin | 21(10) |
| Newly diagnosed | |||
| Cavo M et al, 200432 | 19 | DX + T | 5 (26) |
| Newly diagnosed, age < 65 years | 52 | DX + T + Warfarin (1.2 mg) | 7 (13) |
| Baz R et al, 200533 | 19 | CT + Dx + T | 11 (58) |
| Newly diagnosed and CT refractory | 84 | CT + Dx + T + ASA | 15 (17.8) |
| Reference, disease status . | No. patients . | Therapy . | Thrombosis, n (%) . |
|---|---|---|---|
| Abbreviations: CT, chemotherapy; DX, dexamethasone; T, thalidomide; ASA, aspirin. | |||
| Modified from Falanga and Marchetti44 with permission from the publishers. | |||
| Zangari M et al, 200430 | 68 | CT + DX + T + Enoxaparin (40 mg/d) | 10 (14.7) |
| Newly diagnosed | 35 | CT + DX + T + Warfarin (1 mg/d) | 11 (31.4) |
| Minnema MC et al, 200331 | 209 | CT + DX + T + Nadroparin | 21(10) |
| Newly diagnosed | |||
| Cavo M et al, 200432 | 19 | DX + T | 5 (26) |
| Newly diagnosed, age < 65 years | 52 | DX + T + Warfarin (1.2 mg) | 7 (13) |
| Baz R et al, 200533 | 19 | CT + Dx + T | 11 (58) |
| Newly diagnosed and CT refractory | 84 | CT + Dx + T + ASA | 15 (17.8) |